NCT07141628View on ClinicalTrials.gov

Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4/5 Chronic Kidney Disease

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
CKDCardiovascular Diseases
Interventions
DIAGNOSTIC_TEST

lipoprotein A level dosing

Plasma levels measured in mmol/l

Trial Locations (1)

30029

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER